25 XP   0   0   10

SynCore Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse SynCore Biotechnology Co Ltd together

PenkeI guess you are interested in SynCore Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SynCore Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SynCore Biotechnology Co Ltd

I send you an email if I find something interesting about SynCore Biotechnology Co Ltd.

Quick analysis of SynCore Biotechnology Co Ltd (30 sec.)










What can you expect buying and holding a share of SynCore Biotechnology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
NT$10.16
Expected worth in 1 year
NT$18.15
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
NT$7.99
Return On Investment
17.1%

For what price can you sell your share?

Current Price per Share
NT$46.80
Expected price per share
NT$42.00 - NT$66.63
How sure are you?
50%

1. Valuation of SynCore Biotechnology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$46.80

Intrinsic Value Per Share

NT$-22.69 - NT$-26.43

Total Value Per Share

NT$-12.53 - NT$-16.27

2. Growth of SynCore Biotechnology Co Ltd (5 min.)




Is SynCore Biotechnology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$10.9m$10.3m-$3m-42.1%

How much money is SynCore Biotechnology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$293.9k-$1.4m$1.1m394.3%
Net Profit Margin-266.2%-1,177.9%--

How much money comes from the company's main activities?

3. Financial Health of SynCore Biotechnology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#672 / 1016

Most Revenue
#615 / 1016

Most Profit
#190 / 1016

Most Efficient
#674 / 1016

What can you expect buying and holding a share of SynCore Biotechnology Co Ltd? (5 min.)

Welcome investor! SynCore Biotechnology Co Ltd's management wants to use your money to grow the business. In return you get a share of SynCore Biotechnology Co Ltd.

What can you expect buying and holding a share of SynCore Biotechnology Co Ltd?

First you should know what it really means to hold a share of SynCore Biotechnology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of SynCore Biotechnology Co Ltd is NT$46.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SynCore Biotechnology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SynCore Biotechnology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$10.16. Based on the TTM, the Book Value Change Per Share is NT$2.00 per quarter. Based on the YOY, the Book Value Change Per Share is NT$-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SynCore Biotechnology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.040.1%-0.010.0%-0.010.0%-0.03-0.1%-0.03-0.1%
Usd Book Value Change Per Share0.170.4%0.060.1%-0.010.0%-0.020.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.170.4%0.060.1%-0.010.0%-0.020.0%0.010.0%
Usd Price Per Share1.18-1.31-0.92-1.35-1.32-
Price to Earnings Ratio8.11--8.69--21.33--12.68--12.19-
Price-to-Total Gains Ratio7.13--33.17--81.75--36.05--34.28-
Price to Book Ratio3.78-7.04-10.36-8.18-7.85-
Price-to-Total Gains Ratio7.13--33.17--81.75--36.05--34.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.44144
Number of shares693
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.06-0.02
Usd Total Gains Per Share0.06-0.02
Gains per Quarter (693 shares)42.65-10.61
Gains per Year (693 shares)170.59-42.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101711610-42-52
203413320-85-94
305125030-127-136
406826740-170-178
508538450-212-220
60102410160-255-262
70119411870-297-304
80136513580-339-346
90153515290-382-388
100170617000-424-430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.020.00.04.8%1.020.00.04.8%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%6.015.00.028.6%6.015.00.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%6.015.00.028.6%6.015.00.028.6%

Fundamentals of SynCore Biotechnology Co Ltd

About SynCore Biotechnology Co Ltd

SynCore Biotechnology Co.,Ltd, engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan. The company is involved in the development of SB01, an injectable anti-cancer new ingredient (NCE) that is in Phase II clinical trials for the treatment of head and neck cancer; and SB02, an anti-cancer NCE, which is in preclinical research for use in the treatment of stomach cancer. It also offers SB03-Veregen, an ointment for the treatment of patients with external genital and perianal warts; and SB04,an conventional drug for the treatment of age-related macular degeneration that is in Phase II clinical trials. In addition, the company provides SB05-EndoTAG, an conventional drug for pancreatic cancer and triple-negative breast cancer that is in Phase III clinical trials. Further, it distributes cameras under the epiCam name that is used in recording the progress of ophthalmology diseases. The company has partnerships with Medigene AG and MacuCLEAR Inc.; Sinphar Pharmaceutical Co., Ltd.; and The National Health Research Institutes. SynCore Biotechnology Co.,Ltd was incorporated in 2008 and is headquartered in Yilan City, Taiwan. The company is a subsidiary of Sinphar Pharmaceutical Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-16 22:07:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of SynCore Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit SynCore Biotechnology Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 673.6% means that NT$6.74 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 673.6%. The company is making a huge profit. +2
  • The TTM is -266.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ673.6%TTM-266.2%+939.8%
TTM-266.2%YOY-1,177.9%+911.7%
TTM-266.2%5Y-3,386.4%+3,120.2%
5Y-3,386.4%10Y-3,453.0%+66.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ673.6%-197.2%+870.8%
TTM-266.2%-210.4%-55.8%
YOY-1,177.9%-279.3%-898.6%
5Y-3,386.4%-436.8%-2,949.6%
10Y-3,453.0%-599.3%-2,853.7%
1.1.2. Return on Assets

Shows how efficient SynCore Biotechnology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • 11.0% Return on Assets means that SynCore Biotechnology Co Ltd generated NT$0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 11.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ11.0%TTM-3.1%+14.1%
TTM-3.1%YOY-8.6%+5.5%
TTM-3.1%5Y-9.3%+6.1%
5Y-9.3%10Y-9.4%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%-13.6%+24.6%
TTM-3.1%-12.9%+9.8%
YOY-8.6%-11.9%+3.3%
5Y-9.3%-14.2%+4.9%
10Y-9.4%-16.2%+6.8%
1.1.3. Return on Equity

Shows how efficient SynCore Biotechnology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • 11.7% Return on Equity means SynCore Biotechnology Co Ltd generated NT$0.12 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 11.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -7.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ11.7%TTM-7.5%+19.1%
TTM-7.5%YOY-15.5%+8.0%
TTM-7.5%5Y-15.1%+7.6%
5Y-15.1%10Y-15.0%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-17.0%+28.7%
TTM-7.5%-16.1%+8.6%
YOY-15.5%-15.4%-0.1%
5Y-15.1%-20.0%+4.9%
10Y-15.0%-21.1%+6.1%

1.2. Operating Efficiency of SynCore Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient SynCore Biotechnology Co Ltd is operating .

  • Measures how much profit SynCore Biotechnology Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,214.2%+1,214.2%
TTM-5Y-3,189.6%+3,189.6%
5Y-3,189.6%10Y-3,278.5%+88.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM--224.4%+224.4%
YOY-1,214.2%-288.4%-925.8%
5Y-3,189.6%-475.2%-2,714.4%
10Y-3,278.5%-624.7%-2,653.8%
1.2.2. Operating Ratio

Measures how efficient SynCore Biotechnology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of -2.12 means that the operating costs are NT$-2.12 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of SynCore Biotechnology Co Ltd:

  • The MRQ is -2.123.
  • The TTM is 4.846. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ-2.123TTM4.846-6.969
TTM4.846YOY13.576-8.730
TTM4.8465Y35.685-30.839
5Y35.68510Y36.463-0.778
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.1232.997-5.120
TTM4.8463.247+1.599
YOY13.5763.766+9.810
5Y35.6855.675+30.010
10Y36.4637.857+28.606

1.3. Liquidity of SynCore Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if SynCore Biotechnology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.63 means the company has NT$14.63 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 14.627. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.980. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.627TTM4.980+9.647
TTM4.980YOY1.868+3.112
TTM4.9805Y3.109+1.872
5Y3.10910Y3.370-0.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6273.930+10.697
TTM4.9804.251+0.729
YOY1.8685.436-3.568
5Y3.1096.045-2.936
10Y3.3706.363-2.993
1.3.2. Quick Ratio

Measures if SynCore Biotechnology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.43 means the company can pay off NT$0.43 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 0.429. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.150. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.429TTM0.150+0.279
TTM0.150YOY0.148+0.002
TTM0.1505Y0.107+0.042
5Y0.10710Y0.119-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4293.629-3.200
TTM0.1504.065-3.915
YOY0.1485.397-5.249
5Y0.1075.993-5.886
10Y0.1196.277-6.158

1.4. Solvency of SynCore Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of SynCore Biotechnology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SynCore Biotechnology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that SynCore Biotechnology Co Ltd assets are financed with 5.6% credit (debt) and the remaining percentage (100% - 5.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 0.056. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.344. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.056TTM0.344-0.288
TTM0.344YOY0.453-0.109
TTM0.3445Y0.350-0.007
5Y0.35010Y0.339+0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0560.332-0.276
TTM0.3440.334+0.010
YOY0.4530.268+0.185
5Y0.3500.366-0.016
10Y0.3390.390-0.051
1.4.2. Debt to Equity Ratio

Measures if SynCore Biotechnology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.9% means that company has NT$0.06 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SynCore Biotechnology Co Ltd:

  • The MRQ is 0.059. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.607. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.607-0.547
TTM0.607YOY0.831-0.225
TTM0.6075Y0.585+0.021
5Y0.58510Y0.564+0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.381-0.322
TTM0.6070.390+0.217
YOY0.8310.334+0.497
5Y0.5850.434+0.151
10Y0.5640.466+0.098

2. Market Valuation of SynCore Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings SynCore Biotechnology Co Ltd generates.

  • Above 15 is considered overpriced but always compare SynCore Biotechnology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 8.11 means the investor is paying NT$8.11 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SynCore Biotechnology Co Ltd:

  • The EOD is 9.886. Based on the earnings, the company is underpriced. +1
  • The MRQ is 8.111. Based on the earnings, the company is underpriced. +1
  • The TTM is -8.690. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.886MRQ8.111+1.774
MRQ8.111TTM-8.690+16.801
TTM-8.690YOY-21.330+12.640
TTM-8.6905Y-12.681+3.991
5Y-12.68110Y-12.189-0.492
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.886-2.315+12.201
MRQ8.111-2.560+10.671
TTM-8.690-2.664-6.026
YOY-21.330-4.122-17.208
5Y-12.681-6.258-6.423
10Y-12.189-6.108-6.081
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SynCore Biotechnology Co Ltd:

  • The EOD is -13.583. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.145. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -25.260. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.583MRQ-11.145-2.438
MRQ-11.145TTM-25.260+14.115
TTM-25.260YOY-22.053-3.207
TTM-25.2605Y-20.682-4.578
5Y-20.68210Y-19.806-0.875
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.583-3.067-10.516
MRQ-11.145-3.251-7.894
TTM-25.260-3.545-21.715
YOY-22.053-5.595-16.458
5Y-20.682-8.315-12.367
10Y-19.806-8.708-11.098
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of SynCore Biotechnology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.78 means the investor is paying NT$3.78 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of SynCore Biotechnology Co Ltd:

  • The EOD is 4.608. Based on the equity, the company is fair priced.
  • The MRQ is 3.781. Based on the equity, the company is fair priced.
  • The TTM is 7.037. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.608MRQ3.781+0.827
MRQ3.781TTM7.037-3.256
TTM7.037YOY10.355-3.318
TTM7.0375Y8.183-1.145
5Y8.18310Y7.851+0.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6081.905+2.703
MRQ3.7812.111+1.670
TTM7.0372.095+4.942
YOY10.3552.836+7.519
5Y8.1833.443+4.740
10Y7.8513.794+4.057
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SynCore Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.3861.998+170%-0.421+108%-0.497+109%0.484+1014%
Book Value Per Share--10.1566.729+51%2.922+248%7.288+39%7.898+29%
Current Ratio--14.6274.980+194%1.868+683%3.109+371%3.370+334%
Debt To Asset Ratio--0.0560.344-84%0.453-88%0.350-84%0.339-83%
Debt To Equity Ratio--0.0590.607-90%0.831-93%0.585-90%0.564-89%
Dividend Per Share----0%-0%-0%-0%
Eps--1.184-0.271+123%-0.410+135%-1.005+185%-1.083+191%
Free Cash Flow Per Share---0.861-0.591-31%-0.458-47%-0.931+8%-1.014+18%
Free Cash Flow To Equity Per Share---0.861-0.591-31%-0.617-28%-0.150-83%-0.294-66%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---26.429--------
Intrinsic Value_10Y_min---22.690--------
Intrinsic Value_1Y_max---2.156--------
Intrinsic Value_1Y_min---2.117--------
Intrinsic Value_3Y_max---6.852--------
Intrinsic Value_3Y_min---6.534--------
Intrinsic Value_5Y_max---12.002--------
Intrinsic Value_5Y_min---11.108--------
Market Cap1645722000.000+18%1350336000.0001492539743.500-10%3452310000.000-61%3892008311.200-65%3747951594.000-64%
Net Profit Margin--6.736-2.662+140%-11.779+275%-33.864+603%-34.530+613%
Operating Margin----0%-12.1420%-31.8960%-32.7850%
Operating Ratio---2.1234.846-144%13.576-116%35.685-106%36.463-106%
Pb Ratio4.608+18%3.7817.037-46%10.355-63%8.183-54%7.851-52%
Pe Ratio9.886+18%8.111-8.690+207%-21.330+363%-12.681+256%-12.189+250%
Price Per Share46.800+18%38.40042.444-10%30.000+28%43.801-12%42.889-10%
Price To Free Cash Flow Ratio-13.583-22%-11.145-25.260+127%-22.053+98%-20.682+86%-19.806+78%
Price To Total Gains Ratio8.689+18%7.130-33.166+565%-81.752+1247%-36.052+606%-34.277+581%
Quick Ratio--0.4290.150+186%0.148+190%0.107+299%0.119+260%
Return On Assets--0.110-0.031+128%-0.086+178%-0.093+184%-0.094+185%
Return On Equity--0.117-0.075+164%-0.155+233%-0.151+229%-0.150+229%
Total Gains Per Share--5.3861.998+170%-0.421+108%-0.497+109%0.484+1014%
Usd Book Value--10999788.8007287657.300+51%10356692.500+6%15259458.060-28%15569303.200-29%
Usd Book Value Change Per Share--0.1660.062+170%-0.013+108%-0.015+109%0.015+1014%
Usd Book Value Per Share--0.3130.207+51%0.090+248%0.224+39%0.243+29%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.036-0.008+123%-0.013+135%-0.031+185%-0.033+191%
Usd Free Cash Flow---932962.800-640131.800-31%-1621989.600+74%-1957942.140+110%-2003017.867+115%
Usd Free Cash Flow Per Share---0.027-0.018-31%-0.014-47%-0.029+8%-0.031+18%
Usd Free Cash Flow To Equity Per Share---0.027-0.018-31%-0.019-28%-0.005-83%-0.009-66%
Usd Market Cap50688237.600+18%41590348.80045970224.100-10%106331148.000-61%119873855.985-65%115436909.095-64%
Usd Price Per Share1.441+18%1.1831.307-10%0.924+28%1.349-12%1.321-10%
Usd Profit--1281865.200-293924.400+123%-1452728.200+213%-2299204.600+279%-2325023.067+281%
Usd Revenue--190313.200155509.200+22%122098.900+56%106714.300+78%104460.400+82%
Usd Total Gains Per Share--0.1660.062+170%-0.013+108%-0.015+109%0.015+1014%
 EOD+5 -3MRQTTM+22 -10YOY+23 -95Y+24 -810Y+24 -8

3.2. Fundamental Score

Let's check the fundamental score of SynCore Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.886
Price to Book Ratio (EOD)Between0-14.608
Net Profit Margin (MRQ)Greater than06.736
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.429
Current Ratio (MRQ)Greater than114.627
Debt to Asset Ratio (MRQ)Less than10.056
Debt to Equity Ratio (MRQ)Less than10.059
Return on Equity (MRQ)Greater than0.150.117
Return on Assets (MRQ)Greater than0.050.110
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of SynCore Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.628
Ma 20Greater thanMa 5043.925
Ma 50Greater thanMa 10039.833
Ma 100Greater thanMa 20038.525
OpenGreater thanClose48.100
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -81,73757,809-23,928-2,467-26,395-3,073-29,46871,08741,619
Net Income  -81,73757,809-23,928-2,467-26,395-3,073-29,46871,08741,619
Gross Profit  3,118-1,1152,0035562,5598813,440-10,921-7,481
Operating Income  -82,47457,642-24,832-871-25,703-2,218-27,92160,87532,954
Total Operating Expenses  87,568-59,03228,5361,69430,2303,47733,707-60,482-26,775
Net Income from Continuing Operations  -81,73757,809-23,928-2,467-26,395-3,073-29,46871,08741,619



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets378,362
Total Liabilities21,226
Total Stockholder Equity357,136
 As reported
Total Liabilities 21,226
Total Stockholder Equity+ 357,136
Total Assets = 378,362

Assets

Total Assets378,362
Total Current Assets310,481
Long-term Assets67,881
Total Current Assets
Cash And Cash Equivalents 264,696
Short-term Investments 6,660
Net Receivables 2,436
Inventory 3,123
Other Current Assets 131
Total Current Assets  (as reported)310,481
Total Current Assets  (calculated)277,046
+/- 33,435
Long-term Assets
Property Plant Equipment 4,634
Long-term Assets  (as reported)67,881
Long-term Assets  (calculated)4,634
+/- 63,247

Liabilities & Shareholders' Equity

Total Current Liabilities21,226
Long-term Liabilities0
Total Stockholder Equity357,136
Total Current Liabilities
Short Long Term Debt 162
Other Current Liabilities 165
Total Current Liabilities  (as reported)21,226
Total Current Liabilities  (calculated)327
+/- 20,899
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)357,136
Total Stockholder Equity (calculated)0
+/- 357,136
Other
Capital Stock351,645
Common Stock Shares Outstanding 35,165
Net Invested Capital 357,298
Net Working Capital 289,255
Property Plant and Equipment Gross 4,634



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
804,805
772,575
797,439
918,600
763,876
922,057
1,130,349
1,006,763
913,991
1,224,453
1,001,409
928,560
824,438
788,282
661,425
591,972
436,648
402,600
375,962
279,714
378,362
378,362279,714375,962402,600436,648591,972661,425788,282824,438928,5601,001,4091,224,453913,9911,006,7631,130,349922,057763,876918,600797,439772,575804,805
   > Total Current Assets 
545,238
474,064
515,320
663,535
538,889
708,850
926,351
822,161
741,977
1,064,097
853,623
794,738
710,705
672,008
565,146
498,287
348,233
319,895
296,759
205,944
310,481
310,481205,944296,759319,895348,233498,287565,146672,008710,705794,738853,6231,064,097741,977822,161926,351708,850538,889663,535515,320474,064545,238
       Cash And Cash Equivalents 
472,627
374,146
390,078
531,207
386,351
538,336
697,573
617,413
539,233
859,904
645,941
632,449
552,970
513,260
430,125
358,337
269,145
237,452
224,432
148,176
264,696
264,696148,176224,432237,452269,145358,337430,125513,260552,970632,449645,941859,904539,233617,413697,573538,336386,351531,207390,078374,146472,627
       Short-term Investments 
0
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,660
6,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6600
       Net Receivables 
22,474
1,174
1,460
1,397
24,675
25,512
26,627
27,213
27,336
27,845
1,011
1,021
3,238
31,017
31,680
32,406
32,779
1,714
1,672
2,005
2,436
2,4362,0051,6721,71432,77932,40631,68031,0173,2381,0211,01127,84527,33627,21326,62725,51224,6751,3971,4601,17422,474
       Inventory 
3,618
5,560
3,979
3,198
107,696
109,971
159,814
157,672
157,145
156,053
159,958
119,405
114,038
112,500
86,746
90,371
36,396
18,810
16,849
15,209
3,123
3,12315,20916,84918,81036,39690,37186,746112,500114,038119,405159,958156,053157,145157,672159,814109,971107,6963,1983,9795,5603,618
       Other Current Assets 
34,340
578
2,075
4,351
9,492
10,855
13,596
7,445
7,357
8,217
36,205
31,233
30,065
5,077
6,870
6,923
544
217
281
259
131
1312592812175446,9236,8705,07730,06531,23336,2058,2177,3577,44513,59610,8559,4924,3512,07557834,340
   > Long-term Assets 
0
298,511
282,119
255,065
224,987
213,207
203,998
184,602
172,014
160,356
147,786
133,822
113,733
116,274
96,279
93,685
88,415
82,705
79,203
73,770
67,881
67,88173,77079,20382,70588,41593,68596,279116,274113,733133,822147,786160,356172,014184,602203,998213,207224,987255,065282,119298,5110
       Property Plant Equipment 
12,618
52,675
51,461
47,378
43,173
38,693
33,129
28,045
27,833
23,286
19,089
15,041
11,122
18,902
15,038
18,586
14,811
12,738
9,970
7,260
4,634
4,6347,2609,97012,73814,81118,58615,03818,90211,12215,04119,08923,28627,83328,04533,12938,69343,17347,37851,46152,67512,618
       Long Term Investments 
58,868
66,444
59,606
47,308
30,388
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000030,38847,30859,60666,44458,868
       Intangible Assets 
186,594
177,905
169,565
160,349
151,396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000151,396160,349169,565177,905186,594
       Long-term Assets Other 
0
298,511
282,119
255,065
224,987
213,207
0
0
0
127
43
43
43
43
0
0
0
0
0
0
0
000000043434343127000213,207224,987255,065282,119298,5110
> Total Liabilities 
98,110
122,359
276,098
177,372
151,845
393,117
356,333
340,394
353,412
385,860
250,755
398,182
381,518
384,524
299,215
261,927
187,636
179,135
177,850
111,978
21,226
21,226111,978177,850179,135187,636261,927299,215384,524381,518398,182250,755385,860353,412340,394356,333393,117151,845177,372276,098122,35998,110
   > Total Current Liabilities 
63,338
94,107
251,090
155,620
133,360
347,912
344,419
331,784
348,117
383,397
250,138
398,182
381,518
379,097
295,262
259,452
186,644
179,135
177,850
111,978
21,226
21,226111,978177,850179,135186,644259,452295,262379,097381,518398,182250,138383,397348,117331,784344,419347,912133,360155,620251,09094,10763,338
       Short-term Debt 
0
54,465
165,227
63,987
74,002
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000074,00263,987165,22754,4650
       Short Long Term Debt 
0
54,465
165,227
63,987
74,002
300,473
180,334
180,136
180,351
220,170
100,212
140,093
120,163
120,186
120,393
130,493
60,558
60,236
61,061
94
162
1629461,06160,23660,558130,493120,393120,186120,163140,093100,212220,170180,351180,136180,334300,47374,00263,987165,22754,4650
       Accounts payable 
367
0
0
190
732
782
13,699
13,008
14,031
7,508
6,869
2,951
655
186
724
818
1,208
0
0
75
0
075001,2088187241866552,9516,8697,50814,03113,00813,69978273219000367
       Other Current Liabilities 
62,971
325
366
344
36,916
3,296
3,657
3,056
2,978
3,110
2,728
3,246
3,854
2,527
3,073
6,505
2,373
499
310
211
165
1652113104992,3736,5053,0732,5273,8543,2462,7283,1102,9783,0563,6573,29636,91634436632562,971
   > Long-term Liabilities 
0
28,252
25,008
21,752
18,485
45,205
11,914
8,610
5,295
2,463
617
0
0
5,427
3,953
2,475
992
0
0
0
0
00009922,4753,9535,427006172,4635,2958,61011,91445,20518,48521,75225,00828,2520
       Capital Lease Obligations Min Short Term Debt
0
-13,356
-127,315
-29,283
-42,518
28,252
25,008
21,752
18,485
15,205
11,914
8,610
5,295
13,739
10,437
14,500
11,201
9,246
6,824
4,392
1,952
1,9524,3926,8249,24611,20114,50010,43713,7395,2958,61011,91415,20518,48521,75225,00828,252-42,518-29,283-127,315-13,3560
> Total Stockholder Equity
706,695
650,216
521,341
741,228
612,031
528,940
774,016
666,369
560,579
838,593
750,654
530,378
442,920
403,758
362,210
330,045
249,012
223,465
198,112
167,736
357,136
357,136167,736198,112223,465249,012330,045362,210403,758442,920530,378750,654838,593560,579666,369774,016528,940612,031741,228521,341650,216706,695
   Common Stock
833,670
833,670
833,670
973,670
973,670
973,670
1,065,770
1,065,770
1,065,770
1,150,770
1,150,770
1,150,770
1,150,770
1,150,770
1,150,770
1,150,770
1,150,770
0
0
0
0
00001,150,7701,150,7701,150,7701,150,7701,150,7701,150,7701,150,7701,150,7701,065,7701,065,7701,065,770973,670973,670973,670833,670833,670833,670
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 0000-58,432-59,136-57,562-49,986-53,190-45,867-44,244-44,549-45,628-42,496-36,839-41,673-43,114-26,187-13,859-7,037-14,601



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,196
Cost of Revenue-19,675
Gross Profit521521
 
Operating Income (+$)
Gross Profit521
Operating Expense-65,698
Operating Income-45,502-65,177
 
Operating Expense (+$)
Research Development3,937
Selling General Administrative42,086
Selling And Marketing Expenses0
Operating Expense65,69846,023
 
Net Interest Income (+$)
Interest Income2,369
Interest Expense-784
Other Finance Cost-0
Net Interest Income1,585
 
Pretax Income (+$)
Operating Income-45,502
Net Interest Income1,585
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-38,172-45,502
EBIT - interestExpense = -784
-38,172
-37,388
Interest Expense784
Earnings Before Interest and Taxes (EBIT)0-37,388
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-38,172
Tax Provision-0
Net Income From Continuing Ops-38,172-38,172
Net Income-38,172
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,585
 

Technical Analysis of SynCore Biotechnology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SynCore Biotechnology Co Ltd. The general trend of SynCore Biotechnology Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SynCore Biotechnology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SynCore Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 57.80 < 62.88 < 66.63.

The bearish price targets are: 42.00 > 42.00 > 42.00.

Tweet this
SynCore Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SynCore Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SynCore Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SynCore Biotechnology Co Ltd. The current macd is 2.9690035.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the SynCore Biotechnology Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for SynCore Biotechnology Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the SynCore Biotechnology Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
SynCore Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSynCore Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SynCore Biotechnology Co Ltd. The current adx is 40.87.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy SynCore Biotechnology Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
SynCore Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SynCore Biotechnology Co Ltd. The current sar is 57.80.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
SynCore Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SynCore Biotechnology Co Ltd. The current rsi is 58.63. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
SynCore Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartSynCore Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SynCore Biotechnology Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SynCore Biotechnology Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
SynCore Biotechnology Co Ltd Daily Stochastic Oscillator ChartSynCore Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SynCore Biotechnology Co Ltd. The current cci is 34.12.

SynCore Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartSynCore Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SynCore Biotechnology Co Ltd. The current cmo is 8.54840241.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SynCore Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartSynCore Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SynCore Biotechnology Co Ltd. The current willr is -55.55555556.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that SynCore Biotechnology Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SynCore Biotechnology Co Ltd Daily Williams %R ChartSynCore Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SynCore Biotechnology Co Ltd.

SynCore Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SynCore Biotechnology Co Ltd. The current atr is 2.26767598.

SynCore Biotechnology Co Ltd Daily Average True Range (ATR) ChartSynCore Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SynCore Biotechnology Co Ltd. The current obv is -1,353,419.

SynCore Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartSynCore Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SynCore Biotechnology Co Ltd. The current mfi is 49.59.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SynCore Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartSynCore Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SynCore Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

SynCore Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SynCore Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.628
Ma 20Greater thanMa 5043.925
Ma 50Greater thanMa 10039.833
Ma 100Greater thanMa 20038.525
OpenGreater thanClose48.100
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of SynCore Biotechnology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on SynCore Biotechnology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SynCore Biotechnology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SynCore Biotechnology Co Ltd

I send you an email if I find something interesting about SynCore Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about SynCore Biotechnology Co Ltd.

Receive notifications about SynCore Biotechnology Co Ltd in your mailbox!